Real‐World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression
Regardless of aetiology, patients with low fibrosis risk (MRE) but high disease activity (cT1) face a three-times higher risk of progression. Integrating both biomarkers into standard care, especially for SLD, can guide management adjustments.
Authors
- Mukesh G. Harisinghani (ORCID: https://orcid.org/0000-0003-0993-1947)
- Raymond T. Chung (ORCID: https://orcid.org/0000-0001-7587-718X)
- Kathleen E. Corey (ORCID: https://orcid.org/0000-0003-2882-7264)
- Jessica E.S. Shay (ORCID: https://orcid.org/0000-0001-7799-1349)
- Avinash Kambadakone (ORCID: https://orcid.org/0000-0001-6714-9190)
- Irun Bhan (ORCID: https://orcid.org/0000-0002-2163-0488)
- Emily D. Bethea (ORCID: https://orcid.org/0000-0003-3759-8360)
- Laura E. Dichtel (ORCID: https://orcid.org/0000-0001-6989-2308)
- Karin L. Andersson (ORCID: https://orcid.org/0000-0002-8497-1335)
- Nabih Nakrour (ORCID: https://orcid.org/0009-0000-6402-7585)
- Lawrence S. Friedman
Institutions
- Tufts University (US)
- Harvard University (US)
- Newton Wellesley Hospital (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Liver International
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1111/liv.70280
- Citations
- 11
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 14.90